Moderna

Moderna

Yahoo Finance • 2 hours ago

Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips

Quick Read Moderna shed 7% of Tuesday's 14% Wolfe Research upgrade rally, while BioNTech's 2% dip confirms the selloff is Moderna-specific. IBB barely moved while Moderna's $59 billion cap prices in Merck's unapproved intismeran program a... Full story

Yahoo Finance • 2 hours ago

Meta, Nvidia, Intuit, Salesforce, Moderna, Abercrombie, Zoom, and More Stocks That Explain Today’s Market

Meta Platforms agrees to pay $18 billion to settle a lawsuit over its social media practices, and Nvidia earnings are scheduled for after the closing bell Wednesday. Continue Reading... Full story

Yahoo Finance • 3 hours ago

Moderna Stock Carries A Market Value Its Revenue Does Not Support

Photo by geralt on Pixabay Moderna's commercial business has shrunk and is lossmaking, which puts the weight of its market value on a pipeline rather than on revenue. Moderna (MRNA) has returned about 486% over the trailing twelve months... Full story

Yahoo Finance • 3 hours ago

Wall Street edges lower after inflation data and ahead of Nvidia earnings

[Wall Street New York stock exchange stock market] alexsl Wall Street traded lower on Wednesday as traders assessed a slew of economic data and awaited Nvidia's (NVDA [https://seekingalpha.com/symbol/NVDA]) results. The blue-chip Dow (DJ... Full story

Yahoo Finance • 4 hours ago

U.S. State Banking Associations To Launch Blockchain Network

U.S. State Banking Associations To Launch Blockchain Network Associations that represent banks scattered across U.S. states are planning to launch their own blockchain network. A consortium of 39 state banking associations plans to launc... Full story

Yahoo Finance • 4 hours ago

Merck Stock Hits New 52-Week High: What's Driving the Rally?

Shares of Merck MRK hit a fresh 52-week high yesterday on renewed investor confidence over the company's long-term growth prospects and recent positive developments surrounding its pipeline progress, regulatory approvals, as well as merger... Full story

Yahoo Finance • 4 hours ago

A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity

MarketNewsUpdates.com A New Generation of Personalized Cancer Treatments Could Open a Multibillion-Dollar Market for Precision Oncology NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - If watching where c... Full story

Yahoo Finance • 8 hours ago

Zacks Investment Ideas feature highlights: Bloom Energy, Micron, Nvidia, UBS and Moderna

For Immediate Release Chicago, IL – August 26, 2026 – Today, Zacks Investment Ideas features like Bloom Energy BE, Micron MU, NVIDIA NVDA, UBS UBS and Moderna MRNA 3 Reasons AI Stocks Are Primed for a Rebound Although AI stocks have bee... Full story

Yahoo Finance • 10 hours ago

US Stock Market Today: S&P 500 Futures Rise As Growth Cools And Fed Looms

The Morning Bull - US Market Morning Update Wednesday, Aug, 26 2026 US stock futures are pointing higher this morning, with E-mini S&P 500 contracts up about 0.3% and Nasdaq-100 futures ahead roughly 0.6%. The move comes even as the Chica... Full story

Yahoo Finance • 23 hours ago

Moderna’s Cancer Vaccine Gives Stock a New Growth Story. Will It Have a Happy Ending?

Moderna and Merck’s personalized cancer vaccine could transform cancer treatment and create a multibillion-dollar market, but investors may already be pricing in much of its potential. Continue Reading... Full story

Yahoo Finance • yesterday

Schwab SCHD draws $679M as dividend ETF climbs 2.39%

The Schwab U.S. Dividend Equity ETF (SCHD) pulled in $679.26 million over five trading days as its share price climbed 2.39%, TipRanks reported. Three of the fund's biggest holdings made news in the same stretch, adding fresh fuel to a mo... Full story

Yahoo Finance • yesterday

Moderna Stock Soars on Cancer Vaccine Breakthrough

This article first appeared on GuruFocus. Moderna (NASDAQ:MRNA) shares climbed nearly 13% on Tuesday as investors weighed new analyst support following encouraging results from the company's late-stage cancer program. The move came after... Full story

Yahoo Finance • yesterday

Moderna, Nvidia, Apple, Dick’s, Robinhood, AMD, and More Stocks That Explain Today’s Market

Stocks were modestly higher Tuesday as Wall Street traded cautiously ahead of Nvidia earnings on Wednesday. Moderna gained 14% to $157.92 and was the best-performing stock in the Wolfe Research upgraded the stock to Peer Perform from Un... Full story

Yahoo Finance • yesterday

Wall Street climbs ahead of Nvidia earnings and key inflation data

[Abstract Financial Data Visualization with Digital Stock Market Graphs] AlexSecret Wall Street’s major market averages pushed higher on Tuesday as traders gear up for Nvidia results and inflation data set to land on Wednesday. The blue-... Full story

Yahoo Finance • yesterday

3 Reasons AI Stocks are Primed for a Rebound

Although AI stocks have been highly volatile over the past two months, they likely aren't finished moving higher. Below are three reasons why: The Situational Awareness Saga is Over Last month, momentum stocks, particularly AI stocks, su... Full story

Yahoo Finance • yesterday

Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?

Quick Read Moderna surged 11% while BioNTech gained just 2% on no catalyst, with MRNA's Reddit sentiment score of 88 flagging crowded retail positioning over fundamentals. BioNTech trails XBI's 3% session gain and its 35% YTD return, whil... Full story

Yahoo Finance • yesterday

“Give Me Anything But Tech”: Jim Cramer’s Bold Call on the Market’s Next Big Rotation

Quick Read NOW and CRM surged 30% and 28% in a month as money rotates out of data center plays into software on constrained AI infrastructure. MRNA exploded 115% in one week on melanoma vaccine data showing a 49% reduction in recurrence r... Full story

Yahoo Finance • yesterday

Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.

Quick Read MRK and MRNA's intismeran autogene beat Keytruda alone on recurrence-free survival in Phase 3 melanoma, though no specific efficacy numbers have been released yet. BNTX surged 21% on read-across excitement, while ILMN rose 16%... Full story

Yahoo Finance • 2 days ago

Moderna and Merck Cancer Vaccine Success Is Good News for CancerVax

Positive topline results from Phase 3 trial of personalized cancer vaccine for melanoma de-risk LNP-mRNA therapies such as CancerVax Lehi, Utah, Aug. 24, 2026 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of a breakthrough universal... Full story

Yahoo Finance • 2 days ago

Analysts See Drastic Change For This Particular Part Of Healthcare

The biotech fund is one of two ETFs in IBD Leaderboard. The S&P 500 Biotech index gapped up to nearly an all-time high last Wednesday, a bullish day for the industry. While Moderna shares have remained volatile since then — down 23.5% Th... Full story